| DRC | damage risk criterion; dendritic reticulum cell; diagnostic reporting console; digitorenocerebral [s... |
|---|---|
| FARS | fatal accident reporting system |
| MDR | median duration of response; medical device reporting; minimum daily requirement; multidrug resistan... |
| NFIRS | National Fire Incident Reporting System |
| NRSFPS | National Reporting System for Family Planning Services |
| B | bias |
|---|---|
| BI-RADS | Breast Imaging Reporting And Data System |
| CHART | Craig Handicap Assessment and Reporting Technique |
| DARP | Drug Abuse Reporting Program |
| FARS | Fatal Accident Reporting System |
| bias | <statistics> In a clinical trial, bias refers to effects that a conclusion that may be incorrect as, for example, when a researcher or patient knows what treatment is being given. To avoid bias, a blinded study may be done. Any deviation of results or inferences from the truth, or processes leading to such deviation. Bias can result from several sources: one-sided or systematic variations in measurement from the true value (systematic error); flaws in study design; deviation of inferences, interpretations, or analyses based on flawed data or data collection; etc. There is no sense of prejudice or subjectivity implied in the assessment of bias under these conditions. (27 Jun 1999) |
|---|---|
| publication bias | The influence of study results on the chances of publication and the tendency of investigators, reviewers, and editors to submit or accept manuscripts for publication based on the direction or strength of the study findings. Publication bias has an impact on the interpretation of clinical trials and meta-analyses. Bias can be minimised by insistence by editors on high-quality research, thorough literature reviews, acknowledgement of conflicts of interest, modification of peer review practices, etc. (12 Dec 1998) |
| selection bias | The introduction of error due to systematic differences in the characteristics between those selected and those not selected for a given study. In sampling bias, error is the result of failure to ensure that all members of the reference population have a known chance of selection in the sample. (12 Dec 1998) |
| insurance selection bias | Adverse of favourable selection bias exhibited by insurers or enrollees resulting in disproportionate enrollment of certain groups of people. (12 Dec 1998) |
| internal bias | Applied to the motile behaviour of crawling cells that, in the short term, show persistence and do not behave as true random walkers. Any intrinsic regulation of the random motile behaviour of the cell could be considered as internal bias. (18 Nov 1997) |
| adverse drug reaction reporting systems | Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions. (12 Dec 1998) |
| anonymous reporting | In public health, anonymous reporting permits the acquisition of certain data such as the proportion of persons with a positive test or with a disease. (12 Dec 1998) |
| mandatory reporting | Legal requirement for physicians and other professionals providing health services to report suspected incidents of abuse and neglect. As mandated reporters, they are generally afforded legal immunity for such reports and most jurisdictions impose a civil or criminal penalty for failure to report. (12 Dec 1998) |
| reporting, anonymous | In public health, anonymous reporting permits the acquisition of certain data such as the proportion of persons with a positive test or with a disease. It is different from anonymous testing, in which no name is used on the test sample. (12 Dec 1998) |
| reporting, named | In public health, named reporting is the reporting of infected persons by name to public health departments. This is standard practice for the surveillance of many infectious diseases such as syphilis, gonorrhoea, and tuberculosis that pose a public health threat. The opposite of named reporting is anonymous testing in which the individual remains nameless. (12 Dec 1998) |
| reporting, unique identifier | In public health, a system that uses information such as the person's birth date and part of their identification number (in the u.s., the social security number) to create a unique code that is reported instead of a name. It is an alternative to named reporting that provides some of the surveillance benefits of reporting by name, such as the elimination of duplicate reports, while reducing privacy concerns by avoiding use of a person's name. This system is used with HIV testing for example in maryland and texas. (12 Dec 1998) |
| named reporting | In public health, named reporting is the reporting of infected persons by name to public health departments. This is standard practice for the surveillance of many infectious diseases such as syphilis, gonorrhoea, and tuberculosis that pose a public health threat. The opposite of named reporting is anonymous testing in which the individual remains nameless. (12 Dec 1998) |
| insurance claim reporting | The design, completion, and filing of forms with the insurer. (12 Dec 1998) |
| unique identifier reporting | In public health, a system that uses information such as the person's birth date and part of their identification number (in the u.s., the social security number) to create a unique code that is reported instead of a name. It is an alternative to named reporting that provides some of the surveillance benefits of reporting by name, such as the elimination of duplicate reports, while reducing privacy concerns by avoiding use of a person's name. For example, HIV testing in maryland and texas is done with unique identifier reporting. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|